The outlook of companies tied to Sildenafil's history presents a challenging investment scenario . While the initial success generated substantial gains, generic copies have significantly eroded revenue. https://siambookmark.com/story21656623/copyright-s-flagship-product-and-pharma-a-uncertain-investment